219 



38 



The March 1992 edition of the tobacco industry's trade journal. TR Tobacco 

 Reporter provides further evidence that nicotine research, development, and 

 manipulation continue to be a major focus for the tobacco industry. As an 

 advertisement by LTR Industries (a subsidiary of Kimberly-Clark Corporation) 

 specifically points out: 



Nicotine levels are becoming a growing concern to the designers of 

 modem cigarettes, particularly those with lower "tar" deliveries. The 

 Kimberly-Clark tobacco reconstitution process used by LTR Industries 

 permits adjustments of nicotine to your exact requirements. These 

 adjustments will not affect the other important properties of customized 

 reconstituted tobacco produced at LTR Industries: low tar delivery, high 

 filling power, high yield and the flexibility to convey organoleptic 

 modifications. We can help you control your tobacco. 



The factual evidence from a variety of sources, coupled with the evidence 

 provided by petitioners as part of an earlier filing seeking to classify all low tar 

 and nicotine cigarettes as "drugs " under the Food, Drug and Cosmetic Act, clearly 

 establishes that for many years the tobacco industry has intentionally and 

 deliberately engaged in the research, development and marketing of products 

 subject to drug provisions of the FDC Act. 



